Navigation Links
Award Honors Boston Cancer Survivor Who Gives Back
Date:5/19/2008

ific meeting. Each year, ASTRO partners with local patient advocacy groups that help patients and their families cope with a diagnosis of cancer. Volunteers from these organizations then participate in an exhibit during ASTRO's meeting to help educate the doctors, nurses, therapists and scientists attending the meeting on their services for patients and help raise money for their causes.

"Cancer survivors are a vital link in the battle against this disease. Their experience has caused many to become vocal advocates of cancer funding and research as a way to help lessen the blow of the disease on future generations," said Laura I. Thevenot, ASTRO CEO. "Our goal with this award is honor an individual who is helping pave the way to a cure for cancer and helping others cope with this disease."

Applications for the 2008 Survivor Circle Award must be postmarked by Friday, August 1, 2008. To receive an application, please visit http://www.astro.org/Patients/SurvivorCircle/SurvivorCircleAward/AwardInformation/ documents/survivorcircleaward.pdf or contact Beth Bukata at 703-839-7332.

For more information on ASTRO's 50th Annual Meeting, please visit http://www.astro.org/Meetings/AnnualMeetings/.

For more information on radiation therapy, please visit http://www.rtanswers.org.

ASTRO is the largest radiation oncology society in the world, with more than 9,000 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the Society is dedicated to improving patient care through education, clinical practice, advancement of science and advocacy.


'/>"/>
SOURCE American Society for Therapeutic Radiology and Oncology
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
2. UVa researcher awarded $3.6 million grant to fight drug-resistant bacteria
3. Finicky Felines Award Four Stars to New Wellness(R) Healthy Indulgence Everyday Entrees
4. Award-winning QUITPLAN(R) Services Billboard Debuts in Rogers
5. Minimally Invasive Heart Surgery Research Wins N.I.H. Award
6. MDS Pharma Services Wins Award for Management of Global Malaria Trial
7. Southwest Ambulance Awarded Exclusive, 3-Year Contract Extension in Peoria, Arizona
8. Good Clinical Practice Journal Awards: Winners Announced
9. ComPsych(R) Corp. Announces Health at Work(SM) Award Winners: Sprint, Erie Insurance, City of Naperville and Green Hills Public Library
10. Michigan Hospitals Receive Governors Award
11. Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)... cardiovascular disease , , THURSDAY, Ja...the millions of American men and women with type 2...the day may be symptoms of obstructive sleep apnea... one out of three diabetics. , Based on strong ...obal health experts are encouraging physicians to ...
(Date:1/8/2009)...ta receives $20,000 to support local programs as p... , MINNEAPOLIS, Minn., Jan. 8 /PRNewswire-USNews...eived $20,000 in funding to support Project UNIFY ...tional program. Project UNIFY is an initiative to ...an effort to promote school communities where all ...
(Date:1/8/2009)...e the U.S. Food and Drug Administration Drug has q... complex nature of diseases for which new therapeu...inical development times, according to the Tufts C...verage time for the FDA to approve new drugs decli... average clinical phase time means combined clinic...
(Date:1/8/2009)...8 Warner Chilcott Limite...resent at the 27th Annual JP Morgan Conference on ...ting for Warner Chilcott will be Roger Boissonneau... Herendeen, Executive Vice President and Chief Fin...ion will be webcast live for all interested partie...
Breaking Medicine News(10 mins):Health News:Doctors Urged to Screen Diabetics for Sleep Apnea 2Health News:Doctors Urged to Screen Diabetics for Sleep Apnea 3Health News:Special Olympics Minnesota Launches Project UNIFY to Energize Youth 2Health News:New drug development still takes 8 years despite faster FDA review, according to Tufts CSDD 2
...ts why the commonly prescribed cholesterol-lowerin...h, reported by scientists at Wake Forest Universi... the Journal of Clinical Investigation and will ap...had previously been thought that the drug works by...
...ntified common DNA variations that underlie suscep... of the eight genetic alterations the scientists i... smallpox vaccination. A few, however, reduced fev...possibility the same genetic variations linked to ...
...al conference of the European Society of Human Gen...n undergo chromosomal modifications. Ms Tsvia F...spital, Tel Aviv Sourasky Medical Centre, Tel Aviv...hat her teams findings meant that the results of p...
...arch studies focused primarily on men and the resu...n. But we now know that the biological sex and gen...an skin deep. Beginning in 1990, the Society for W...advocacy organization, conveyed to a national audi...
Other Medicine News:Health News:Animal Research Uncovers Another Mechanism of Cholesterol Lowering Drug 2Health News:Genetic Variations Leads to Fever After Smallpox Vaccination 2Health News:Genetic Variations Leads to Fever After Smallpox Vaccination 3Health News:Preimplanted Genetic Screening Should Be Interpreted With Caution 2Health News:Rare Womens Lung Disease May Yield Insights Into Common Diseases 2
(Date:1/8/2009).... 8 If you are taking prescription... alone. Half of the people taking,prescription me...e,varied -- they forget, are busy with other prio...ompliance has been called the Achilles heel of mod... Koop commented, "Drugs don,t,work in people who ...
(Date:1/8/2009)... at the initial dose in an ongoing Phase Ib trial ... after three days , , Conference Call Today at ...irstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq:...ohort of an ongoing Phase Ib clinical trial of ANA...polymerase inhibitor. ANA598 was very well-tolera...
(Date:1/7/2009)...Jan. 7 Scientists have ... likelihood of relapse in children with acute lymp... caution that further research is needed to determ...AROS, lead to leukemia relapse, the findings are ...tests to assess the risk of treatment failure. By ...
(Date:1/7/2009)...Jan. 7 ImQuest Life Sciences annou...lication to the Food and Drug Administration to in...dinedione HIV inhibitor IQP-0410. ImQuest anticipa...quarter of 2009. IQP-0410 is a novel small molecul...cleoside reverse transcriptase inhibitor (NNRTI). ...
Breaking Medicine Technology:Good Medicine: Smarter Smartphones for People With Chronic Disease 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2Trial Date Set for Victim Hit by Ambulance 14985 1Trial Date Set for Victim Hit by Ambulance 14985 2Millennium Biotechnologies Inc Signs Marketing and Distribution Agreement with Ferring Pharmaceuticals 4149 1Millennium Biotechnologies Inc Signs Marketing and Distribution Agreement with Ferring Pharmaceuticals 4149 2Millennium Biotechnologies Inc Signs Marketing and Distribution Agreement with Ferring Pharmaceuticals 4149 3FAAN Brings Food Allergies 3A Living and Learning to Annual Food Allergy Conference in Baltimore 14977 1FAAN Brings Food Allergies 3A Living and Learning to Annual Food Allergy Conference in Baltimore 14977 2FAAN Brings Food Allergies 3A Living and Learning to Annual Food Allergy Conference in Baltimore 14977 3St Jude Study Offers New Hope for Children With Kidney Tumors Deemed Inoperable 1585 1St Jude Study Offers New Hope for Children With Kidney Tumors Deemed Inoperable 1585 2
...Md., April 25, 2007-The U.S. Food and Drug,Adminis...ree of,Permanent Injunction against PharmaFab Inc....ls, Mark Tengler, PharmaFab,s president,and Russ ...rs, to,stop the illegal manufacture and distributi...cts. The products are illegal because,they are not...
...ralia 24 April 2007. Giaconda Ltd (ASX: GIA) today...n (FDA) has,approved the Company,s Investigational...opment of MyocondaR to treat patients with,Crohn,s...atuberculosis (MAP). , ,The Company understands th...py to be submitted to the FDA for this indication....
Other Medicine Technology:Major Manufacturer of Unapproved and Adulterated Drugs 2Major Manufacturer of Unapproved and Adulterated Drugs 3FDA approves MyocondaR IND for MAP in Crohn's Disease 2FDA approves MyocondaR IND for MAP in Crohn's Disease 3FDA approves MyocondaR IND for MAP in Crohn's Disease 4
... in providing versatile liquid handling platforms ...livers even more flexibility and possibilities for...er with the new easy-to-use software, Freedom EVOw...te genomics, proteomics, and drug discovery applic...
...om DePuy offers a comprehensive combination of com...ecommendations regarding occupational exposure to ...rd for comfort. , ,The PROVISION System is de...htweight, hose-free, bicycle helmet design. , ,...
...rpness and efficiency with an innovative and compr...asty. Advanced trephine blade technology provides...ritical fit needed for successful transplants. Th...tem enables surgeons to select the style and size ...
Misys Laboratory is a comprehensive, high-performance, information system that manages specimen data from requisition entry through specimen tracking to final cumulative report production. Misys Labo
Medicine Products: